A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Clinical trial NCT06388200 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06388200
- Sponsor
- Ocugen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-18
- Primary completion
- 2027-02-12
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.